2289 - Organ Preservation-First Strategy Following Total Neoadjuvant Chemoradiotherapy for MRI-Defined Low-Risk Rectal Cancer: Early Results from a Prospective, Single-Center, Phase II Trial (PKUCH-R08)

03:00pm - 04:00pm ET

Presenter(s)

Yangzi Zhang, MD - Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, Beijing, Beijing